|119.72||+3.64 / +3.14%|
Data as of Dec 18
|121.16||+1.44 / +1.20%|
The 6 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 102.00, with a high estimate of 124.00 and a low estimate of 76.00. The median estimate represents a -14.80% decrease from the last price of 119.72.
The current consensus among 7 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.